Naomi Livni
Overview
Explore the profile of Naomi Livni including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
449
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wedge D, Gundem G, Mitchell T, Woodcock D, Martincorena I, Ghori M, et al.
Nat Genet
. 2018 Apr;
50(5):682-692.
PMID: 29662167
Prostate cancer represents a substantial clinical challenge because it is difficult to predict outcome and advanced disease is often fatal. We sequenced the whole genomes of 112 primary and metastatic...
2.
Camacho N, Van Loo P, Edwards S, Kay J, Matthews L, Haase K, et al.
PLoS Genet
. 2017 Sep;
13(9):e1007001.
PMID: 28945760
A variety of models have been proposed to explain regions of recurrent somatic copy number alteration (SCNA) in human cancer. Our study employs Whole Genome DNA Sequence (WGS) data from...
3.
Castro E, Mikropoulos C, Bancroft E, Dadaev T, Goh C, Taylor N, et al.
Oncologist
. 2016 May;
21(6):716-22.
PMID: 27151655
Background: A better assessment of individualized prostate cancer (PrCa) risk is needed to improve screening. The use of the prostate-specific antigen (PSA) level for screening in the general population has...
4.
Cooper C, Eeles R, Wedge D, Van Loo P, Gundem G, Alexandrov L, et al.
Nat Genet
. 2015 May;
47(6):689.
PMID: 26018901
No abstract available.
5.
Cooper C, Eeles R, Wedge D, Van Loo P, Gundem G, Alexandrov L, et al.
Nat Genet
. 2015 Mar;
47(4):367-372.
PMID: 25730763
Genome-wide DNA sequencing was used to decrypt the phylogeny of multiple samples from distinct areas of cancer and morphologically normal tissue taken from the prostates of three men. Mutations were...
6.
Karavitakis M, Ahmed H, Abel P, Livni N, Hazell S, Winkler M
Prostate
. 2012 Feb;
72(13):1464-8.
PMID: 22328187
Background: We aimed to evaluate the trends in pathologic outcomes of clinically localized prostate cancer treated with radical prostatectomy prior to and after national guidelines placing active surveillance as the...
7.
Thway K, du Parcq J, Larkin J, Fisher C, Livni N
Ann Diagn Pathol
. 2011 Jun;
16(5):407-10.
PMID: 21684183
Mucinous tubular and spindle cell carcinoma (MTSCC) is a rare, distinctive renal neoplasm characterized by an admixture of cuboidal cells in tubules and sheets of spindle cells, typically with low-grade...
8.
Larkin J, Fisher R, Pickering L, Thway K, Livni N, Fisher C, et al.
J Clin Oncol
. 2010 Aug;
28(28):e539-40.
PMID: 20679595
No abstract available.
9.
Akhtar K, Lee G, Khan M, Mitchell A, Livni N, Christmas T
Br J Hosp Med (Lond)
. 2010 Jan;
71(1):52.
PMID: 20081645
This article presents the case of a 56-year-old woman who developed a tumour recurrence following radical nephrectomy. This was invading the descending colon and causing severe gastrointestinal haemorrhage. Angiography revealed...
10.
Wang J, Cook G, Frank J, Dina R, Livni N, Lynn J, et al.
BMC Cancer
. 2007 Aug;
7:147.
PMID: 17683560
Background: The use of combined positron emission tomography/computerised tomography (PET/CT) scanners in oncology has been shown to improve the staging of tumours and the detection of relapses. However, mis-registration errors...